Home › Funds › BNP Paribas Asset Management Holding S.A. › JNJ

BNP Paribas Asset Management Holding S.A. position in JNJ

JOHNSON & JOHNSON · Health Care

BNP Paribas Asset Management Holding S.A. reported holding 1,547,853 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$409.9M, representing 0.41% of its reported portfolio and ranking #38 among its reported holdings. BNP Paribas Asset Management Holding S.A. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.55M sh
Reported value held$409.86M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BNP Paribas Asset Management Holding S.A.'s JNJ position evolved

BNP Paribas Asset Management Holding S.A. first disclosed a stake in JNJ in Q3 2023 at 687,813 shares (US$107.1M). The position peaked in Q4 2025 at 2,385,419 shares, worth US$493.7M. Across 13 filings, BNP Paribas Asset Management Holding S.A. increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,547,853 shares valued at US$409.9M — a reduction of -110,075 shares quarter over quarter.. Notable position changes include a 50% trim in Q3 2024 (shares fell 11% over the following quarter), a 43% increase in Q4 2024 (shares rose 12% over the following quarter), a 332% increase in Q4 2025 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 687.81K $107.13M New
Q4 2023 587.58K $92.10M Reduce
Q1 2024 443.83K $70.21M Reduce
Q2 2024 535.25K $78.23M Add
Q3 2024 267.83K $43.40M Reduce
Q4 2024 383.54K $55.47M Add
Q1 2025 512.40K $84.98M Add
Q2 2025 450.32K $68.79M Reduce
Q3 2025 551.92K $100.91M Add
Q4 2025 2.39M $493.70M Add
Q1 2026 1.64M $401.47M Reduce
Q2 2026 1.66M $421.18M Add
Q3 2026 1.55M $409.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has BNP Paribas Asset Management Holding S.A. held JNJ?

BNP Paribas Asset Management Holding S.A. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BNP Paribas Asset Management Holding S.A.'s current position in JNJ?

As of Q3 2026, BNP Paribas Asset Management Holding S.A. holds 1.55M shares of JNJ (JOHNSON & JOHNSON), valued at $409.86M, representing 0.41% of its reported portfolio and ranking #38.

Has BNP Paribas Asset Management Holding S.A. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), BNP Paribas Asset Management Holding S.A. reduced its position in JNJ. The position peaked in Q4 2025 at 2.39M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.